Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Potent boosted protease inhibitor for HIV with resistance. | Boosted protease inhibitor for HIV, mostly used as a second-line option. |
| Body system | Antivirals | Antivirals |
| Drug class | Viral protease inhibitors | Viral protease inhibitors |
| Supply | Prescription only | Prescription onlyWHO essential medicine |
| Main uses | HIV infection (with other drugs) | HIV infection (with other drugs) |
| How it works | Stops HIV from maturing into infectious viruses. | Stops HIV from maturing into infectious viruses. |
| Starts working | Weeks | Weeks |
| Half-life | About 15 hours (boosted) | 5–6 hours |
| Typical adult dose | 800 mg with 100 mg ritonavir once a day (600/100 mg twice a day if resistant). | 400/100 mg twice a day, or 800/200 mg once a day in some patients. |
| Forms | Tablet, Oral suspension, Combination tablets | Tablet, Oral solution |
| Common side effects | Diarrhoea, Nausea, Headache, Rash | Diarrhoea, Nausea, Raised cholesterol and triglycerides, Tiredness |
| Serious side effects | Severe skin reactions, Liver injury, Raised cholesterol and glucose | Pancreatitis, Liver injury, QT and PR prolongation, Insulin resistance |
| Don't take if | Severe liver disease; Taking simvastatin or rifampicin; Allergy to sulfonamides (caution) | Taking simvastatin, lovastatin, rifampicin, St John's wort; Severe liver disease |
| Alcohol | Best to limit. Alcohol adds to liver strain. | Best to limit. Alcohol increases pancreatitis and liver risk. |
| Pregnancy | Use with cautionLimited data; only if essential. | Generally considered safeWidely used in pregnancy within HIV regimens. |
| Breastfeeding | Usually avoidedNot recommended where safe formula is available. | Usually avoidedNot recommended where safe formula is available. |
| In use since | — | — |
| Brand names | United States: Prezista, PrezcobixUnited Kingdom: Prezista, RezolstaIndia: Prezista, Darunavir (generic) | United States: KaletraUnited Kingdom: KaletraIndia: Lopimune, Lopinavir-ritonavir (generic) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | J05AE10 | J05AR10 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker